Recurrent wheezing, allergic rhinitis, and maternal asthma as predictors of asthma in children

Ilson Meireles-Neto1, Alexandre M Pimentel1, Juliana N Parreira2

  • 1From the Department of Medicine and Public Health, Bahiana School of Medicine, Bahiana Foundation for Science Development, Salvador, Brazil; and.

Insights

Recurrent wheezing in early childhood significantly increases asthma risk. Maternal asthma and atopic rhinitis in children are also key predictors for developing childhood asthma.

Area of Science:

  • Pediatric Pulmonology
  • Epidemiology
  • Allergy and Immunology

Background:

  • Early asthma prediction is vital for effective prevention strategies.
  • Identifying risk factors in early childhood aids in timely intervention.
  • Asthma prevalence and its early indicators remain a significant public health concern.

Purpose of the Study:

  • To determine the odds ratio (OR) of recurrent wheezing, atopic rhinitis, and maternal asthma for predicting childhood asthma.
  • To investigate early life risk factors for asthma development in school-aged children.
  • To provide data for improved early diagnosis and management of pediatric asthma.

Main Methods:

  • A case-control study conducted in Salvador, Brazil, involving 125 asthma cases and 375 controls.
  • Review of medical records to gather data on wheezing episodes, maternal asthma history, and personal atopic rhinitis.
  • Logistic regression analysis was used to calculate adjusted odds ratios for identified risk factors.

Main Results:

  • Children with ≥3 wheezing episodes in the first 3 years had an adjusted OR of 132.5 for developing asthma.
  • A personal history of atopic rhinitis showed an adjusted OR of 21.3 for childhood asthma.
  • Maternal asthma history presented an adjusted OR of 10.2 for asthma in school-aged children.

Conclusions:

  • Three or more wheezing episodes in early life are strong predictors of childhood asthma.
  • Maternal asthma history and personal atopic rhinitis are significant risk factors for pediatric asthma.
  • Early identification of these factors can facilitate targeted asthma prevention and management programs.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K